| Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis N Ahmad, SD Ahuja, OW Akkerman, JWC Alffenaar, LF Anderson, ... The Lancet 392 (10150), 821-834, 2018 | 515 | 2018 |
| Diabetes mellitus and tuberculosis facts and controversies P Baghaei, M Marjani, P Javanmard, P Tabarsi, MR Masjedi Journal of Diabetes & Metabolic Disorders 12, 1-8, 2013 | 220 | 2013 |
| Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis Z Lan, N Ahmad, P Baghaei, L Barkane, A Benedetti, SK Brode, ... The Lancet Respiratory Medicine 8 (4), 383-394, 2020 | 192 | 2020 |
| Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis F Fregonese, SD Ahuja, OW Akkerman, D Arakaki-Sanchez, I Ayakaka, ... The lancet respiratory medicine 6 (4), 265-275, 2018 | 102 | 2018 |
| Outcome of treatment of MDR-TB patients with standardised regimens, Iran, 2002–2006 MR Masjedi, P Tabarsi, E Chitsaz, P Baghaei, M Mirsaeidi, MV Amiri, ... The International Journal of Tuberculosis and Lung Disease 12 (7), 750-755, 2008 | 93 | 2008 |
| Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial F Dastan, SA Nadji, A Saffaei, M Marjani, A Moniri, H Jamaati, ... International immunopharmacology 85, 106688, 2020 | 90 | 2020 |
| Incidence, clinical and epidemiological risk factors, and outcome of drug-induced hepatitis due to antituberculous agents in new tuberculosis cases P Baghaei, P Tabarsi, E Chitsaz, M Saleh, M Marjani, S Shemirani, ... American journal of therapeutics 17 (1), 17-22, 2010 | 87 | 2010 |
| Adverse effects of multidrug-resistant tuberculosis treatment with a standardized regimen: a report from Iran P Baghaei, P Tabarsi, D Dorriz, M Marjani, M Shamaei, MV Pooramiri, ... American journal of therapeutics 18 (2), e29-e34, 2011 | 81 | 2011 |
| Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017. Treatment correlates of successful outcomes in pulmonary multidrug-resistant … N Ahmad, SD Ahuja, OW Akkerman, JC Alffenaar, LF Anderson, ... Lancet 392 (10150), 821-834, 2018 | 79 | 2018 |
| Early risks of death, stroke/systemic embolism, and major bleeding in patients with newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry JP Bassand, S Virdone, SZ Goldhaber, AJ Camm, DA Fitzmaurice, ... Circulation 139 (6), 787-798, 2019 | 76 | 2019 |
| Nontuberculous mycobacteria among patients who are suspected for multidrug-resistant tuberculosis—need for earlier identification of nontuberculosis mycobacteria P Tabarsi, P Baghaei, P Farnia, N Mansouri, E Chitsaz, F Sheikholeslam, ... The American journal of the medical sciences 337 (3), 182-184, 2009 | 75 | 2009 |
| Promising effects of tocilizumab in COVID-19: a non-controlled, prospective clinical trial F Dastan, A Saffaei, S Haseli, M Marjani, A Moniri, Z Abtahian, A Abedini, ... International immunopharmacology 88, 106869, 2020 | 63 | 2020 |
| Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis GP Bisson, M Bastos, JR Campbell, D Bang, JC Brust, P Isaakidis, ... The Lancet 396 (10248), 402-411, 2020 | 59 | 2020 |
| Management and 1‐year outcomes of patients with newly diagnosed atrial fibrillation and chronic kidney disease: results from the prospective GARFIELD‐AF registry S Goto, P Angchaisuksiri, JP Bassand, AJ Camm, H Dominguez, ... Journal of the American Heart Association 8 (3), e010510, 2019 | 59 | 2019 |
| Early initiation of antiretroviral therapy results in decreased morbidity and mortality among patients with TB and HIV P Tabarsi, AS Saber-Tehrani, P Baghaei, M Padyab, D Mansouri, M Amiri, ... Journal of the International AIDS Society 12, 1-6, 2009 | 58 | 2009 |
| Pulmonary disease caused by Mycobacterium simiae in Iran’s national referral center for tuberculosis P Baghaei, P Tabarsi, P Farnia, M Marjani, FM Sheikholeslami, M Chitsaz, ... The Journal of Infection in Developing Countries 6 (01), 23-28, 2012 | 57 | 2012 |
| Rumen fermentation and microbial community composition influenced by live Enterococcus faecium supplementation LL Mamuad, SH Kim, AA Biswas, Z Yu, KK Cho, SB Kim, K Lee, SS Lee Amb Express 9 (1), 123, 2019 | 52* | 2019 |
| Changes in glycosylated haemoglobin and treatment outcomes in patients with tuberculosis in Iran: a cohort study P Tabarsi, P Baghaei, M Marjani, WM Vollmer, MR Masjedi, AD Harries Journal of Diabetes & Metabolic Disorders 13, 1-6, 2014 | 50 | 2014 |
| Treatment outcome, mortality and their predictors among HIV-associated tuberculosis patients P Tabarsi, E Chitsaz, A Moradi, P Baghaei, P Farnia, M Marjani, ... International journal of STD & AIDS 23 (9), e1-e4, 2012 | 46 | 2012 |
| Tuberculosis-associated secondary pneumothorax: a retrospective study of 53 patients M Shamaei, P Tabarsi, S Pojhan, L Ghorbani, P Baghaei, M Marjani, ... Respiratory care 56 (3), 298-302, 2011 | 46 | 2011 |
P.TabarsiCTERC, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, IranVerified email at sbmu.ac.ir
